Navigation Links
Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
Date:10/30/2010

rates," said Stefan Zeuzem, MD, Chief of the Department of Medicine and Professor of Medicine at the Johann Wolfgang Goethe University Hospital in Frankfurt, Germany and lead investigator of the study. "An interferon-sparing regimen could provide an important treatment option for patients with chronic hepatitis C."Proportion of patients with viral load <25 IU/mlDay 8Day 15Day 22Day 29400mg TID BI 207127 + BI 201335 + RBV

4/15

6/15

10/15

11/15600mg TID BI 207127 + BI 201335 + RBV

3/17

14/17

17/17

17/17The PegIFN sparing treatment was well tolerated. Investigators reported that the most common adverse events observed in the study were mild gastro-intestinal effects (diarrhea, nausea, vomiting), rash or photosensitivity. Laboratory parameters did not indicate any relevant changes from baseline, except for a continuous drop in amino alanine transferase (ALT) in all patients, a decrease of hemoglobin (median -1.7 and -2.6 g/dL) and an increase of unconjugated bilirubin (median +9.8 and +11.5 umol/L) similar to reported results from earlier BI 201335 trials. There were no serious or severe adverse events and no discontinuations due to adverse events reported in the study during treatment with BI 207127 and BI 201335. A phase IIb trial testing different dose regimens of this combination with longer durations is planned to evaluate sustained virological response rates.

Additional studies to be presented at AASLD

  • Virological response and safety of 4 weeks treatment with the protease inhibitor BI 201335 combined with 48 weeks of peginterferon alpha 2a and ribavirin for treatment of HCV GT-1 patients who failed peginterferon / ribavirin
    (Poster 804. T. Berg, et al. Sun, October 31 - 8:00 AM. Hynes: Exhibit Hall C)

  • Genotypic and phenotypic analysis of the NS5B polymerase region from viral isolates of HCV chronically infected patients treated with
    '/>"/>


  • SOURCE Boehringer Ingelheim Pharmaceuticals
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
    3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
    4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    5. Tapestry Reports Second Quarter 2007 Results
    6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
    7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
    8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
    9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
    10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
    11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/4/2015)... March 4, 2015 Sanomedics , ... a medical technology company that focuses on providing ... that the Company,s subsidiary, Thermomedics, Inc. , has ... and Government Sales. LeBel will be reporting to ... Sales, and will be responsible for supporting assigned ...
    (Date:3/4/2015)... DIEGO , March 4, 2015  Imprimis Pharmaceuticals, ... focused on the development and commercialization of proprietary compounded ... fourth quarter and fiscal year 2014 financial results on ... conference call at 4:30 p.m. EDT (1:30 p.m. PDT) ... and report on recent business activities.  The conference call ...
    (Date:3/4/2015)... DUBLIN , March 4, 2015   Mallinckrodt ... specialty biopharmaceutical company, will present at the Barclays Global ... Miami, Florida , on Wednesday, March 11, ... will represent the company in a session scheduled to ... cannot attend the meeting in person can find webcast ...
    Breaking Medicine Technology:Sanomedics Hires Scott W. LeBel as Director of Specialty and Government Sales 2Sanomedics Hires Scott W. LeBel as Director of Specialty and Government Sales 3Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 2Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 3Mallinckrodt to Present at Barclays Conference March 11 2
    ... Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) ... that Pharma Tech International (PTI), a joint venture of ... $500,000 minimum sales agreement with Cure Hands, a company ... In the agreement, Pharma Tech International, the exclusive distributor ...
    ... A poster entitled, "Time to Progression in ... versus Degarelix Following Leuprolide Treatment," is being presented ... David Crawford, MD, head of the Section of Urologic ... in Denver, and lead study investigator. The full manuscript ...
    Cached Medicine Technology:International Sales Agreement Signed by WNDM Subsidiary; $500K First-Year Sales Commitment 2International Sales Agreement Signed by WNDM Subsidiary; $500K First-Year Sales Commitment 3International Sales Agreement Signed by WNDM Subsidiary; $500K First-Year Sales Commitment 4Exploratory Efficacy Analysis Conducted for Long-Term Extension Study in Patients With Prostate Cancer Treated With FIRMAGON® or Crossed Over to FIRMAGON From Leuprolide 2Exploratory Efficacy Analysis Conducted for Long-Term Extension Study in Patients With Prostate Cancer Treated With FIRMAGON® or Crossed Over to FIRMAGON From Leuprolide 3Exploratory Efficacy Analysis Conducted for Long-Term Extension Study in Patients With Prostate Cancer Treated With FIRMAGON® or Crossed Over to FIRMAGON From Leuprolide 4Exploratory Efficacy Analysis Conducted for Long-Term Extension Study in Patients With Prostate Cancer Treated With FIRMAGON® or Crossed Over to FIRMAGON From Leuprolide 5
    (Date:3/4/2015)... (PRWEB) March 04, 2015 Cook For ... organization that teaches healthy cooking to people touched by ... Hope Lodge. The program, run by founder Ann Ogden, ... and Sport Management. The unique partnership will expand the ... Ogden founded CFYL in 2007. After going through her ...
    (Date:3/4/2015)... Blake’s All Natural Foods , a leader ... year’s Natural Products Expo West in Anaheim, California, showcasing ... line, Blake’s, who has the top four selling frozen ... to creating high-quality dishes that are easily prepared. , ... channel, Blake’s understands what educated consumers are looking for ...
    (Date:3/4/2015)... 2015 Alliance Healthcare Foundation (AHF), a ... those in need in San Diego and Imperial Counties, ... its Mission Support Grants program with awards totaling $1 ... for AHF’s Mission Support Grants program. Grant recipients were ... trustees and program committee, as well as the community ...
    (Date:3/4/2015)... Texas (PRWEB) March 04, 2015 ... , Endometriosis can be a painful condition ... starts spreading outside of the uterus leading to very ... their families. Endometriosis can have a terrible effect on ... It is also the most common cause of infertility ...
    (Date:3/4/2015)... La Farge, Wis. (PRWEB) March 04, 2015 ... a leading organic brand, today announced its cause campaign to ... has gone viral and is making a difference to Bros ... million views on Youtube and Facebook. The video was ... and was featured in Forbes, Mashable and Digiday, among other ...
    Breaking Medicine News(10 mins):Health News:Drexel University and Cook for Your Life Team Up 2Health News:Drexel University and Cook for Your Life Team Up 3Health News:Drexel University and Cook for Your Life Team Up 4Health News:Drexel University and Cook for Your Life Team Up 5Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 2Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 3Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3
    ... still looking for a date for Valentine,s Day? Here,s some dating ... something to "playing hard to get." A study published in ... finds that a woman is more attracted to a man when ... On the one hand, a lot of psychological research has found ...
    ... million, five-year grant from the National Cancer Institute will ... called Latinos Contra El Cancer, to reduce cancer-related health ... a joint project of The University of Texas Health ... and The University of Texas MD Anderson Cancer Center. ...
    ... 7, 2011 Geneva, Switzerland. Following the publication of ... fraud discovered in grants financed by the Global Fund ... Society (IAS) urges all donors and governments to continue ... and innovative financing instrument which attracts, manages and disburses ...
    ... A digital signal processing technique long used by statisticians ... roots of memory and learning, Alzheimer,s and Parkinson,s diseases ... University of Texas Health Science Center at Houston (UTHealth) ... that single molecule fluorescence resonance energy transfer (FRET) ...
    ... works, an anthropologist tackles a perplexing question relating to the ... and even celebrate the public display of human corpses? ... Human Bodies " is the most widely attended exhibit in ... anthropology at the University of Illinois and author of a ...
    ... , MONDAY, Feb. 7 (HealthDay News) -- Living ... health risks such as smoking or obesity, researchers have ... families, Cornell University researchers asked 17-year-olds and their mothers ... measure of how connected their community is and the ...
    Cached Medicine News:Health News:'He loves me, he loves me not...': Women are more attracted to men whose feelings are unclear 2Health News:Project connects researchers, Latino communities to prevent cancer 2Health News:Project connects researchers, Latino communities to prevent cancer 3Health News:Media reports ignore that Global Fund resources deliver tremendous results in the fight against AIDS 2Health News:Researchers get a grip on nervous system's receptors 2Health News:Researchers get a grip on nervous system's receptors 3Health News:Anthropologist: 'Body Worlds' visitors confront bodies but not death 2Health News:Anthropologist: 'Body Worlds' visitors confront bodies but not death 3Health News:Community Has a Role in Health of Low-Income Kids 2
    The IR 1000 Insulin Infusion Pump from Animas offers unprecedented safety features, performance, and convenience....
    SPR treats pigmented and vascular lesions, skin aging, sun damaged skin and fine lines and wrinkles with clinically proven LHE technology....
    Inquire...
    Sebia's Hb AFSC Control provides excellent resolution of normal hemoglobins A & F and abnormal hemoglobins S & C. The control is designed for use with Sebia's Hydragel Hemoglobin and Hydragel Acid He...
    Medicine Products: